Clinical Trials Directory

Trials / Suspended

SuspendedNCT00448162

The Chinese Mutation Hotspot of ENaC Causing Liddle's Syndrome and the Association of ENaC Variations and Hypertension

Status
Suspended
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Peking Union Medical College · Academic / Other
Sex
All
Age
8 Years – 70 Years
Healthy volunteers
Accepted

Summary

The variations of ENaC have an impact on the degradation of epithelial sodium channels and sodium reabsorption, and thus are associated with hypertension and hypokalemia. Liddle's syndrome is a rare monogenic form of autosomal-dominant hypertension caused by truncating or missense mutations in the C-termini of epithelial sodium channel β- or γ-subunit encoded by SCNN1B or SCNN1G. Our purpose is to determine the hotspot of mutation causing Chinese Liddle's syndrome. The second purpose is to determine wether the polymorphisms of ENaC are associated with hypertension in Chinese. Some polymorphisms of ENaC associated with hypertension may be genetic risk factors for Chinese hypertension.

Conditions

Timeline

Start date
2005-05-01
Completion
2009-12-01
First posted
2007-03-16
Last updated
2011-03-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00448162. Inclusion in this directory is not an endorsement.